These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 212275

  • 1. Prednisolone-3,20-bisguanylhydrazone: the mode of interaction with rat brain sodium and potassium-activated adenosine triphosphatase.
    Yamamoto S.
    Eur J Pharmacol; 1978 Aug 15; 50(4):409-18. PubMed ID: 212275
    [Abstract] [Full Text] [Related]

  • 2. Cardiac Na+,K+-ATPase isoenzymes: sensitivity to prednisolone bisguanylhydrazone.
    Ng YC, Leung WY, Akera T.
    Eur J Pharmacol; 1988 Oct 11; 155(1-2):93-9. PubMed ID: 2854075
    [Abstract] [Full Text] [Related]

  • 3. Prednisolone-3, 20-bisguanylhydrazone: Na+, K+-ATPase inhibition and positive inotropic action.
    Yamamoto S, Akera T, Brody TM.
    Eur J Pharmacol; 1978 May 15; 49(2):121-32. PubMed ID: 149010
    [Abstract] [Full Text] [Related]

  • 4. Kinetics studies on the interaction between ouabain and (Na+,K+)-ATPase.
    Choi YR, Akera T.
    Biochim Biophys Acta; 1977 Apr 12; 481(2):648-59. PubMed ID: 139932
    [Abstract] [Full Text] [Related]

  • 5. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase.
    Finotti P, Palatini P.
    J Pharmacol Exp Ther; 1981 Jun 12; 217(3):784-90. PubMed ID: 6262496
    [Abstract] [Full Text] [Related]

  • 6. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
    Coughlin RT, Akera T, McGroarty EJ, Steinbach C.
    Mol Pharmacol; 1987 Jul 12; 32(1):147-53. PubMed ID: 3037299
    [Abstract] [Full Text] [Related]

  • 7. Aging: effects on sodium- and potassium-activated adenosine triphosphatase activity and ouabain binding sites in rat brain.
    Kennedy RH, Akera T, Katano Y.
    J Gerontol; 1985 Jul 12; 40(4):401-8. PubMed ID: 2989353
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
    Tal DM, Karlish SJ.
    Mol Pharmacol; 1988 Sep 12; 34(3):245-9. PubMed ID: 2843743
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of 5-hydroxytryptamine on sodium- and potassium-dependent adenosine triphosphatase and its reactivity toward ouabain.
    Stepp LR, Novakoski MA.
    Arch Biochem Biophys; 1997 Jan 01; 337(1):43-53. PubMed ID: 8990266
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of a third isoform of Na+, K(+)-ATPase activity in rat brain synaptosomes.
    Foley TD, Linnoila M.
    Life Sci; 1993 Jan 01; 52(24):PL273-8. PubMed ID: 8389408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Autoradiographic visualization and characterization of [3H]ouabain binding to the Na+,K+-ATPase of rat brain and pineal.
    Caspers ML, Schwartz RD, Labarca R, Paul SM.
    Brain Res; 1987 Apr 21; 409(2):335-42. PubMed ID: 3034380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.